Search Within

Lukas Kraehenbuehl

Formats
  1. Journal Article (8)
  2. Meeting Abstract (6)
  3. Review (3)
  4. Correspondence (1)
  5. Guidelines (1)
Groups
  1. Department of Medicine (19)
  2. Sloan Kettering Institute Postdocs (19)
  3. Dermatology (16)
  4. Dermatology Service (16)
  5. Division of Subspecialty Medicine (16)
  6. Survivorship Research (15)

More Groups

People
  1. Mario Lacouture (13)
  2. Kwami Ketosugbo (8)
  3. Andrea Moy (6)
  4. Taha Merghoub (6)
  5. Alyce Kuo (5)
  6. Aliya Holland (4)

More People

Years
  1. 2024 (4)
  2. 2023 (1)
  3. 2022 (11)
  4. 2021 (3)
Publications
  1. Annals of Allergy, Asthma & Immunology (3)
  2. Cancers (2)
  3. Journal for ImmunoTherapy of Cancer (2)
  4. Journal of Allergy and Clinical Immunology (2)
  5. Breast Cancer Research and Treatment (1)
  6. Clinical Cancer Research (1)

More Publications

Publishers
  1. Elsevier Inc. (3)
  2. Mosby Elsevier (3)
  3. Biomed Central Ltd (2)
  4. Elsevier Science, Inc. (2)
  5. MDPI (2)
  6. Nature Publishing Group (2)

More Publishers

Results (19)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Contribution of the skin–gut axis to immune-related adverse events with multi-system involvement
    Journal Article

    Kuo, A. M.; Kraehenbuehl, L.; King, S.; Leung, D. Y. M.; Goleva, E.; Moy, A. P.; Lacouture, M. E.; Shah, N. J.; Faleck, D. M.
    Cancers (2022)

    Fulltext@MSK | Save
  • Pilot trial of arginine deprivation plus nivolumab and ipilimumab in patients with metastatic uveal melanoma
    Journal Article

    Kraehenbuehl, L.; Holland, A.; Armstrong, E.; O'Shea, S.; Mangarin, L.; Chekalil, S.; Johnston, A.; Bomalaski, J. S.; Erinjeri, J. P.; Barker, C. A.; more...
    Cancers (2022)

    Fulltext@MSK | Save
  • Checkpoint inhibition induced pruritus during cancer therapy is associated with skin IL-31 and CCL22 expression
    Meeting Abstract

    Wang, E.; Lyubchenko, T.; Goleva, E.; Kraehenbuehl, L.; Ketosugbo, K.; Moy, A.; Hellmann, M.; Kern, J.; Lacouture, M.; Leung, D.
    Journal of Allergy and Clinical Immunology (2022)

    Fulltext@MSK | Save
  • Dermatological adverse events in prostate cancer patients treated with the androgen receptor inhibitor apalutamide
    Journal Article

    Pan, A.; Reingold, R. E.; Zhao, J. L.; Moy, A.; Kraehenbuehl, L.; Dranitsaris, G.; McBride, S. M.; Scher, H. I.; Kollmeier, M. A.; Xiao, H.; more...
    Journal of Urology (2022)

    Fulltext@MSK | Save
  • European recommendations for management of immune checkpoint inhibitors-derived dermatologic adverse events. The EADV task force ‘Dermatology for cancer patients’ position statement
    Guidelines

    Apalla, Z.; Nikolaou, V.; Fattore, D.; Fabbrocini, G.; Freites-Martinez, A.; Sollena, P.; Lacouture, M.; Kraehenbuehl, L.; Stratigos, A.; Peris, K.; more...
    Journal of the European Academy of Dermatology and Venereology (2022)

    Fulltext@MSK | Save
  • Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways
    Review

    Kraehenbuehl, L.; Weng, C. H.; Eghbali, S.; Wolchok, J. D.; Merghoub, T.
    Nature Reviews Clinical Oncology (2022)

    Fulltext@MSK | Save
  • T cell immunotherapies trigger neutrophil activation to eliminate tumor antigen escape variants
    Meeting Abstract

    Hirschhorn, D.; Budhu, S.; Schröder, D.; Kraehenbuehl, L.; Flammar, A. L.; Chow, A.; Schulze, I.; Schad, S.; Ricca, J.; Gasmi, B.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Our current understanding of checkpoint inhibitor therapy in cancer immunotherapy
    Review

    Goleva, E.; Lyubchenko, T.; Kraehenbuehl, L.; Lacouture, M. E.; Leung, D. Y. M.; Kern, J. A.
    Annals of Allergy, Asthma & Immunology (2021)

    Fulltext@MSK | Save
  • Immune-related cutaneous adverse events due to checkpoint inhibitors
    Review

    Wang, E.; Kraehenbuehl, L.; Ketosugbo, K.; Kern, J. A.; Lacouture, M. E.; Leung, D. Y. M.
    Annals of Allergy, Asthma & Immunology (2021)

    Fulltext@MSK | Save